| Trial name or title |
A randomised controlled cross‐over pilot study of meropenem standard 30‐minute infusion vs prolonged 3‐hour infusion in intensive care patients |
| Methods |
Randomised, open‐label trial |
| Participants |
Enrolment = 10, adults in intensive care |
| Interventions |
Meropenem 1 g i.v. infused over 30 minutes q8h (if creatinine clearance > 50 mL/min) OR q12h (if creatinine clearance < 50 mL/min) vs meropenem 500 mg i.v. infused over 3 h q8h (if creatinine clearance > 50 mL/min) OR q12h (if creatinine clearance < 50 mL/min) |
| Outcomes |
Primary outcome: time above MIC |
| Starting date |
April 2009 |
| Contact information |
Katherine Langan (Katherine.Langan@monash.edu.au) |
| Notes |
Study completed January 2010, data not published (no clinical outcomes measured) |
